About Seres Therapeutics
Seres Therapeutics is a company based in Cambridge (United States) founded in 2010 by David Berry.. Seres Therapeutics has raised $257.13 million across 9 funding rounds from investors including ARE, Flagship Pioneering and Nestlé Health Science. The company has 103 employees as of December 31, 2024. Seres Therapeutics offers products and services including Live Biotherapeutics and GoodNature Program. Seres Therapeutics operates in a competitive market with competitors including Biogen, Denali Therapeutics, UCB, Grifols and MiRagen, among others.
- Headquarter Cambridge, United States
- Employees 103 as on 31 Dec, 2024
- Founders David Berry
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Seres Therapeutics, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-146.57 M-28.88as on Dec 31, 2024
-
EBITDA
$-103.35 M42.58as on Dec 31, 2024
-
Total Equity Funding
$257.13 M (USD)
in 9 rounds
-
Latest Funding Round
-
Investors
ARE
& 6 more
-
Employee Count
103
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Seres Therapeutics
Seres Therapeutics is a publicly listed company on the NASDAQ with ticker symbol MCRB in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Seres Therapeutics
Seres Therapeutics offers a comprehensive portfolio of products and services, including Live Biotherapeutics and GoodNature Program. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treats bacterial infections and GI diseases through innovative biotherapeutics.
Facilitates stool donations for biotherapeutics research and development.
Unlock access to complete
Unlock access to complete
Leadership Team
19 people
Software Development Team
15 people
Scientific Team
6 people
Product Management Team
6 people
Operations Team
5 people
Senior Team
5 people
Board Team
4 people
Human Resources and Administration
4 people
Unlock access to complete
Funding Insights of Seres Therapeutics
Seres Therapeutics has successfully raised a total of $257.13M across 9 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Last Round
-
First Round
First Round
(21 Nov 2013)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2024 | Amount | Post-IPO - Seres Therapeutics | Valuation |
investors |
|
| Nov, 2017 | Amount | Grant - Seres Therapeutics | Valuation |
investors |
|
| Jan, 2015 | Amount | Series D - Seres Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Seres Therapeutics
Seres Therapeutics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Flagship Pioneering and Nestlé Health Science. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Life sciences-focused venture capital firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Seres Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Seres Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Seres Therapeutics Comparisons
Competitors of Seres Therapeutics
Seres Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, Denali Therapeutics, UCB, Grifols and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Therapies for immunological and neurological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Plasma-derived therapies are developed to treat multiple diseases.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Small molecule protein degraders are developed for various disorders.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Seres Therapeutics
Frequently Asked Questions about Seres Therapeutics
When was Seres Therapeutics founded?
Seres Therapeutics was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Where is Seres Therapeutics located?
Seres Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Seres Therapeutics a funded company?
Seres Therapeutics is a funded company, having raised a total of $257.13M across 9 funding rounds to date. The company's 1st funding round was a Series D of $65M, raised on Nov 21, 2013.
How many employees does Seres Therapeutics have?
As of Dec 31, 2024, the latest employee count at Seres Therapeutics is 103.
What does Seres Therapeutics do?
Seres Therapeutics was founded in 2010 and is based in Cambridge, United States. Operations center on the biotechnology sector, where microbiome-based therapeutics are created for treating conditions such as C. difficile infection, antibiotic-resistant infections, graft-versus-host disease, and ulcerative colitis. The pipeline includes candidates like SER-109, SER-155, and SER-287, with development focused on clinical advancement and therapeutic applications.
Who are the top competitors of Seres Therapeutics?
Seres Therapeutics's top competitors include Kymeratx, PureTech Health and Poseida Therapeutics.
What products or services does Seres Therapeutics offer?
Seres Therapeutics offers Live Biotherapeutics and GoodNature Program.
Is Seres Therapeutics publicly traded?
Yes, Seres Therapeutics is publicly traded on NASDAQ under the ticker symbol MCRB.
Who are Seres Therapeutics's investors?
Seres Therapeutics has 7 investors. Key investors include ARE, Flagship Pioneering, Nestlé Health Science, CARB-X, and Ludicrous Ventures.
What is Seres Therapeutics's ticker symbol?
The ticker symbol of Seres Therapeutics is MCRB on NASDAQ.